Leena Gandhi
Deenanath Mangeshkar Hospital and Research Center(IN)Dana-Farber Cancer Institute(US)Celldex Therapeutics (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer(2018)6,458 cited
- → Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer(2015)6,153 cited
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints(2016)1,544 cited
- → Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study(2016)1,385 cited
- → Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study(2012)1,275 cited